GRK2 inhibition by βARKct is successful in vivo and could improve the disease symptoms of heart failure in numerous experimental cardiovascular disease models of mouse, rat, rabbit and porcine origins [15,110,111,112]. This evidence concerns the gene GRK2 and heart failure.